Combination of weekly topotecan and gemcitabine as a salvage treatment in patients with recurrent ovarian cancer: a phase I study.
CONCLUSIONS: The weekly administration of gemcitabine/topotecan regimen in patients with pretreated metastatic ovarian cancer is an active chemotherapy combination, even in heavily pretreated patients, with a manageable toxicity profile which merits further investigation.
PMID: 30727721 [PubMed - as supplied by publisher]
Source: Minerva Ginecologica - Category: OBGYN Tags: Minerva Ginecol Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Epithelial Cancer | Greece Health | Hematology | Ovarian Cancer | Ovaries | Study | Thrombocytopenia | Toxicology | Women